GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma

Clinical trial NCT02295722 · TERMINATED

Trial details

NCT number: NCT02295722
Sponsor: AHS Cancer Control Alberta
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hodgkin's Lymphoma - Relapsed/Refractory Non-Hodgkin's Lymphoma - Aggressive Follicular Lymphoma

Start date: 2015-04-01
Primary completion: 2023-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.